» Articles » PMID: 9798822

Interpretation of Cost-effectiveness Analyses

Overview
Publisher Springer
Specialty General Medicine
Date 1998 Nov 3
PMID 9798822
Citations 81
Authors
Affiliations
Soon will be listed here.
Citing Articles

Dapagliflozin for the treatment of heart failure with reduced ejection fraction in Brazil: a cost-effectiveness analysis.

Naves M, Amato A, Zimmermann I, Peixoto H Lancet Reg Health Am. 2025; 42():100968.

PMID: 39835255 PMC: 11742827. DOI: 10.1016/j.lana.2024.100968.


Estimating the Cost-Saving Threshold of a Rural Syringe Services Program Before and During the COVID-19 Pandemic.

Allen S, Weir B, Reid M, Schneider K, ORourke A, Hazelett T AIDS Behav. 2025; .

PMID: 39832079 DOI: 10.1007/s10461-025-04615-z.


Home-monitoring/remote optical coherence tomography in teleophthalmology in patients with eye disorders-a systematic review.

Dolar-Szczasny J, Drab A, Rejdak R Front Med (Lausanne). 2024; 11:1442758.

PMID: 39512616 PMC: 11540653. DOI: 10.3389/fmed.2024.1442758.


Cost-Effectiveness of GaitSmart and an Artificial Intelligence Solution for Rehabilitation of Patients Undergoing Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA) in Older Population in the United Kingdom.

Zanghelini F, Ponzo A, Xydopoulos G, Fordham R, Khanal S Geriatrics (Basel). 2024; 9(5).

PMID: 39451861 PMC: 11508099. DOI: 10.3390/geriatrics9050129.


Association of mental health related quality of life and other factors with treatment seeking for substance use disorders: A comparison of SUDs rooted in legal, partially legal, and illegal substances.

Havlik J, Rhee T, Rosenheck R PLoS One. 2024; 19(4):e0302544.

PMID: 38683850 PMC: 11057773. DOI: 10.1371/journal.pone.0302544.


References
1.
Naylor C, Williams J, Basinski A, Goel V . Technology assessment and cost-effectiveness analysis: misguided guidelines?. CMAJ. 1993; 148(6):921-4. PMC: 1490754. View

2.
Azimi N, Welch H . The effectiveness of cost-effectiveness analysis in containing costs. J Gen Intern Med. 1998; 13(10):664-9. PMC: 1500894. DOI: 10.1046/j.1525-1497.1998.00201.x. View

3.
Garber A, Phelps C . Economic foundations of cost-effectiveness analysis. J Health Econ. 1997; 16(1):1-31. DOI: 10.1016/s0167-6296(96)00506-1. View

4.
Laupacis A, Feeny D, Detsky A, Tugwell P . Tentative guidelines for using clinical and economic evaluations revisited. CMAJ. 1993; 148(6):927-9. PMC: 1490721. View

5.
Weinstein M . Economic assessments of medical practices and technologies. Med Decis Making. 1981; 1(4):309-30. DOI: 10.1177/0272989X8100100403. View